Team Rankings
Explore complete teams ranked by observed Usage Rate. Compare the published population, then open a composition to inspect its evidence.
The Team Rankings page is built around answering one question:
Which teams are used most often across recent endgame content?
To answer that, we compare complete four-Character teams across up to the latest 3 published cycles. 2 cycles are currently available. Use Team Comp Finder to explore teams containing a particular Character.
- Eligibility:
A team needs at least 20 observations in at least one independent encounter context to appear. Once it qualifies, its count includes all accepted positive observations across the selected compatible contexts, including smaller fragments. Two samples of 19 alone do not qualify.
- Usage Rate:
A qualifying team's complete count divided by all 286,886 accepted team observations across the selected encounters, including unpublished teams. Counts are pooled before division; equal counts share a rank. Supported-context coverage still counts only contexts with at least 20 observations, not every positive fragment.
- Team identity:
The same four Characters form one team regardless of their order. Overall totals are not added to individual halves or battlefields, and overlapping Stygian difficulty samples are not counted twice.
- Scope:
Both halves of the highest available Abyss floor. These capped published lists show accepted team observations, not unique players or every team played. Absence from a list is not proof of zero use.
- Performance:
This ranking measures usage, not strength. Comparable performance and investment data are unavailable, so it has no Team Index or investment filter.
Data & sources
Data comes from YShelper public aggregate statistics. AstraVoy independently calculates the displayed statistics and creates their visualizations.
Cycle starts: 7.0 · Phase I (2026-08-16); 7.0 · Phase II (2026-09-16). Exact cycle end dates are unavailable.
View YShelperObserved team rankings
2 recent cycles, 286,886 observations, 844 eligible compositions
| Rank | Team | Usage Rate | Observations | Team evidence |
|---|---|---|---|---|
| #794<0.01% Usage Rate |     | <0.01% | 25 observations | |
| #788<0.01% Usage Rate |    | <0.01% | 26 observations | |
| #788<0.01% Usage Rate |   | <0.01% | 26 observations | |
| #788<0.01% Usage Rate |    | <0.01% | 26 observations | |
| #788<0.01% Usage Rate |    | <0.01% | 26 observations | |
| #788<0.01% Usage Rate |   | <0.01% | 26 observations | |
| #788<0.01% Usage Rate |  | <0.01% | 26 observations | |
| #767<0.01% Usage Rate |  | <0.01% | 27 observations | |
| #767<0.01% Usage Rate |  | <0.01% | 27 observations | |
| #767<0.01% Usage Rate | | <0.01% | 27 observations | |
| #767<0.01% Usage Rate |    | <0.01% | 27 observations | |
| #767<0.01% Usage Rate |  | <0.01% | 27 observations | |
| #767<0.01% Usage Rate |  | <0.01% | 27 observations | |
| #767<0.01% Usage Rate |  | <0.01% | 27 observations | |
| #767<0.01% Usage Rate |   | <0.01% | 27 observations | |
| #767<0.01% Usage Rate |  | <0.01% | 27 observations | |
| #767<0.01% Usage Rate |    | <0.01% | 27 observations | |
| #767<0.01% Usage Rate |   | <0.01% | 27 observations | |
| #767<0.01% Usage Rate | | <0.01% | 27 observations | |
| #767<0.01% Usage Rate |  | <0.01% | 27 observations | |
| #767<0.01% Usage Rate | | <0.01% | 27 observations | |
| #767<0.01% Usage Rate |  | <0.01% | 27 observations | |
| #767<0.01% Usage Rate |  | <0.01% | 27 observations | |
| #767<0.01% Usage Rate | | <0.01% | 27 observations | |
| #767<0.01% Usage Rate | | <0.01% | 27 observations | |
| #767<0.01% Usage Rate | | <0.01% | 27 observations | |
| #767<0.01% Usage Rate | | <0.01% | 27 observations | |
| #767<0.01% Usage Rate |  | <0.01% | 27 observations | |
| #764<0.01% Usage Rate | | <0.01% | 28 observations | |
| #764<0.01% Usage Rate |  | <0.01% | 28 observations | |
| #764<0.01% Usage Rate |  | <0.01% | 28 observations | |
| #7560.01% Usage Rate |  | 0.01% | 29 observations | |
| #7560.01% Usage Rate |   | 0.01% | 29 observations | |
| #7560.01% Usage Rate |  | 0.01% | 29 observations | |
| #7560.01% Usage Rate | | 0.01% | 29 observations | |
| #7560.01% Usage Rate |  | 0.01% | 29 observations | |
| #7560.01% Usage Rate |  | 0.01% | 29 observations | |
| #7560.01% Usage Rate | | 0.01% | 29 observations | |
| #7560.01% Usage Rate |  | 0.01% | 29 observations | |
| #7360.01% Usage Rate |  | 0.01% | 30 observations | |
| #7360.01% Usage Rate |  | 0.01% | 30 observations | |
| #7360.01% Usage Rate | | 0.01% | 30 observations | |
| #7360.01% Usage Rate | | 0.01% | 30 observations | |
| #7360.01% Usage Rate |  | 0.01% | 30 observations | |
| #7360.01% Usage Rate | | 0.01% | 30 observations | |
| #7360.01% Usage Rate | | 0.01% | 30 observations | |
| #7360.01% Usage Rate | | 0.01% | 30 observations | |
| #7360.01% Usage Rate | | 0.01% | 30 observations | |
| #7360.01% Usage Rate | | 0.01% | 30 observations | |
| #7360.01% Usage Rate |  | 0.01% | 30 observations |